AU Patent

AU2005212405B2 — Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors

Assigned to Bristol Myers Squibb Holdings Ireland ULC · Expires 2010-08-12 · 16y expired

What this patent protects

Patent listed against Sprycel.

Drugs covered by this patent

Patent Metadata

Patent number
AU2005212405B2
Jurisdiction
AU
Classification
—
Expires
2010-08-12
Drug substance claim
No
Drug product claim
No
Assignee
Bristol Myers Squibb Holdings Ireland ULC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.